<DOC>
	<DOCNO>NCT00241137</DOCNO>
	<brief_summary>The purpose evaluate valsartan 320mg compare valsartan 160 mg term blood pressure reduction patient population mild moderate hypertensive</brief_summary>
	<brief_title>A Study Compare Treating Hypertension With Valsartan 160 MG Valsartan 320 Mg</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>â€¢ Male female age 1880 year age , inclusive Diagnosed enrollment ( visit 2 ) mild moderate hypertensive MSDBP &gt; = 95 = &lt; 109 mmHg non treat patient . Previously treat patient MSDBP = &lt; 109 mmHg visit 1 MSDBP &gt; = 95 = &lt; 109 mmHg visit 2 . Written inform consent participate study prior study procedure Ability communicate comply study requirement Severe hypertension ( grade 3 WHO classification ; &gt; = 110 mmHg diastolic and/or &gt; = 180 mmHg systolic ) . Malignant hypertension Inability discontinue prior antihypertensive medication safely period 2 week , require protocol . Known history proteinuria ( great 0.3 gram per day ) Female patient either postmenopausal one year surgically sterile , use effective contraceptive method barrier method spermicidal intrauterine device . Oral contraceptive use allow . Known KeithWagener grade III IV hypertensive retinopathy . History hypertensive encephalopathy cerebrovascular accident anytime prior Visit 1 . Transient ischemic cerebral attack last 12 month prior Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>hypertension</keyword>
	<keyword>valsartan</keyword>
</DOC>